![PDF) Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and dexamethasone for docetaxel-refractory prostate cancer PDF) Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and dexamethasone for docetaxel-refractory prostate cancer](https://i1.rgstatic.net/publication/321376988_Feasibility_of_metronomic_chemotherapy_with_tegafur-uracil_cisplatin_and_dexamethasone_for_docetaxel-refractory_prostate_cancer/links/5a39b00baca2728e69879386/largepreview.png)
PDF) Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and dexamethasone for docetaxel-refractory prostate cancer
![PDF) TEGAFIRI is an effective alternative regimen for the management of recurrent or metastatic colorectal cancer PDF) TEGAFIRI is an effective alternative regimen for the management of recurrent or metastatic colorectal cancer](https://i1.rgstatic.net/publication/272097530_TEGAFIRI_is_an_effective_alternative_regimen_for_the_management_of_recurrent_or_metastatic_colorectal_cancer/links/54ed14db0cf27fbfd7720e63/largepreview.png)
PDF) TEGAFIRI is an effective alternative regimen for the management of recurrent or metastatic colorectal cancer
![Concomitant Chemoradiotherapy Using Carboplatin, Tegafur-Uracil and Leucovorin for Stage III and IV Head-and-Neck Cancer: Results of GORTEC Phase II Study - International Journal of Radiation Oncology, Biology, Physics Concomitant Chemoradiotherapy Using Carboplatin, Tegafur-Uracil and Leucovorin for Stage III and IV Head-and-Neck Cancer: Results of GORTEC Phase II Study - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2002797791/2010174073/gr1.jpg)
Concomitant Chemoradiotherapy Using Carboplatin, Tegafur-Uracil and Leucovorin for Stage III and IV Head-and-Neck Cancer: Results of GORTEC Phase II Study - International Journal of Radiation Oncology, Biology, Physics
![Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine - ScienceDirect Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1533002817300336-gr1.jpg)
Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine - ScienceDirect
![PDF) Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study PDF) Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study](https://i1.rgstatic.net/publication/311623216_Maintenance_treatment_of_Uracil_and_Tegafur_UFT_in_responders_following_first-line_fluorouracil-based_chemotherapy_in_metastatic_gastric_cancer_a_randomized_phase_II_study/links/5851647708aef7d0309d06b7/largepreview.png)
PDF) Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study
![Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment? - European Journal of Cancer Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment? - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/24364/116258/gr1.gif)
Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment? - European Journal of Cancer
![Pathologic downstaging of T3–4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur - International Journal of Radiation Oncology, Biology, Physics Pathologic downstaging of T3–4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2004836024/2020450749/gr1.jpg)
Pathologic downstaging of T3–4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur - International Journal of Radiation Oncology, Biology, Physics
![A Combined Pharmacokinetic–Pharmacodynamic (PK–PD) Model for Tumor Growth in the Rat with UFT Administration - Journal of Pharmaceutical Sciences A Combined Pharmacokinetic–Pharmacodynamic (PK–PD) Model for Tumor Growth in the Rat with UFT Administration - Journal of Pharmaceutical Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2046479653/2057604554/gr1.gif)
A Combined Pharmacokinetic–Pharmacodynamic (PK–PD) Model for Tumor Growth in the Rat with UFT Administration - Journal of Pharmaceutical Sciences
![PDF) Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study | PIlar Zamora - Academia.edu PDF) Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study | PIlar Zamora - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/46980860/mini_magick20190208-23866-3k54d1.png?1549626119)
PDF) Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study | PIlar Zamora - Academia.edu
![Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial - The Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial - The](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f2bd48fd-5958-4322-a4ac-7968aa18ae60/gr1.gif)